|
|
Article: Screening for colorectal cancer - United States, 1992-1993, and new guidelines.
- Article from:
- MMWR. Morbidity and Mortality Weekly Report
- Article date:
- February 9, 1996
CopyrightCOPYRIGHT 1996 U.S. Government Printing Office. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Colorectal cancer is the third most commonly diagnosed cancer for both men and women in the United States and is the second leading cause of cancer-related deaths (1). During 1996, approximately 133,500 new cases of colorectal cancer will be diagnosed, and 54,900 persons will die from the disease (1). Recent evidence of the efficacy of colorectal cancer screening to reduce mortality was reviewed by the U.S. Preventive Services Task Force (USPSTF), an independent expert advisory panel to the Public Health Service (2). The revised USPSTF recommendations on cancer screening suggest that the risk for colorectal cancer-related mortality can be reduced by the use of specific ...
<$15,000 annually, 35% reported a DRE, and 24% reported a proctosigmoidoscopy; among those earning>